CONCORDANCE OF COMBINATION AND SINGLE AGENT CHEMOSENSITIVITY PREDICTION IN OVARIAN-CARCINOMA USING THE SUBRENAL CAPSULE XENOGRAFT ASSAY (SRCA)

被引：3
|
作者：
STRATTON, JA [1 ]
RETTENMAIER, MA [1 ]
KUCERA, PR [1 ]
BERMAN, ML [1 ]
DISAIA, PJ [1 ]
机构：
[1] WOMENS HOSP,MEM MED CTR LONG BEACH,LONG BEACH,CA 90806
来源：
GYNECOLOGIC ONCOLOGY | 1988年 / 30卷 / 03期
关键词：
D O I：
10.1016/0090-8258(88)90256-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：416 / 421
页数：6
相关论文
共 9 条
  • [1] ACCURATE PREDICTION OF EXPERIMENTAL CANCER CHEMOSENSITIVITY USING THE SUBRENAL CAPSULE XENOGRAFT ASSAY
    BENNETT, JA
    PILON, VA
    UPPAL, GS
    MCKNEALLY, MF
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1986, 33 (01) : 8 - 13
  • [2] ACCURATE PREDICTION OF THE CHEMOSENSITIVITY OF LEWIS LUNG-CARCINOMA (LL) USING A SUBRENAL CAPSULE ASSAY (SRC) IN RATS
    BENNETT, JA
    MCKNEALLY, MF
    PREVOSTI, L
    PILON, V
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 373 - 373
  • [3] SINGLE-AGENT ADRIAMYCIN FOLLOWED BY COMBINATION "HEXAMETHYLMELAMINE-CYCLOPHOSPHAMIDE FOR ADVANCED OVARIAN-CARCINOMA
    WHARTON, JT
    HERSON, J
    EDWARDS, CL
    GRIFFITH, AB
    [J]. GYNECOLOGIC ONCOLOGY, 1982, 14 (02) : 262 - 270
  • [4] A PROSPECTIVE RANDOMIZED STUDY OF CIS-PLATINUM AS A SINGLE AGENT AND IN COMBINATION WITH CHLORAMBUCIL IN ADVANCED OVARIAN-CARCINOMA
    KANKIPATI, SR
    WILTSHAW, E
    [J]. BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 289 - 289
  • [5] CHEMOSENSITIVITY TESTING OF HUMAN TUMORS USING A MICROPLATE ADENOSINE-TRIPHOSPHATE LUMINESCENCE ASSAY - CLINICAL CORRELATION FOR CISPLATIN RESISTANCE OF OVARIAN-CARCINOMA
    ANDREOTTI, PE
    CREE, IA
    KURBACHER, CM
    HARTMANN, DM
    LINDER, D
    HAREL, G
    GLEIBERMAN, I
    CARUSO, PA
    RICKS, SH
    UNTCH, M
    SARTORI, C
    BRUCKNER, HW
    [J]. CANCER RESEARCH, 1995, 55 (22) : 5276 - 5282
  • [6] ADVANCED OVARIAN-CARCINOMA - PILOT-STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) IN COMBINATION WITH ADRIAMYCIN AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS AND AS A SINGLE AGENT IN PREVIOUSLY TREATED PATIENTS
    WILLIAMS, CJ
    STEVENSON, KE
    BUCHANAN, RB
    WHITEHOUSE, JMA
    [J]. CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1745 - 1753
  • [7] Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment
    Ballard, Karen S.
    Homesley, Howard D.
    Hodson, Charles
    Presant, Cary A.
    Rutledge, James
    Hallquist, Allan
    Perree, Mathieu
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2010, 21 (01) : 45 - 49
  • [8] Single agent and combination treatment studies with the telomerase inhibitor GRN163L in ovarian cancer and non-small cell lung carcinoma (NSCLC) xenograft models
    Go, N.
    Li, Y.
    Tressler, R.
    [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 189 - 189
  • [9] Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: implications for endometrial cancer treatment
    Ballard, K.
    Homesley, H.
    Hodson, C.
    Presant, C.
    Rutledge, J.
    Hallquist, A.
    Perree, M.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 595 - 595
1